Volume 63, Issue 1, Pages (January 2003)

Slides:



Advertisements
Similar presentations
Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,
Advertisements

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
Volume 72, Issue 1, Pages (July 2007)
Reduced renal function in patients with simple renal cysts
Volume 66, Issue 4, Pages (October 2004)
Volume 54, Issue 2, Pages (August 1998)
Iron status and iron supplementation in peritoneal dialysis patients
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients  Demetrios J. Kutsogiannis, R.T.Noel.
Continuous renal replacement therapy in the critically ill patient
John M. Arthur, M.D.Ph.D., Shazia Shamim  Kidney International 
Section 5: Dialysis Interventions for Treatment of AKI
Volume 77, Issue 1, Pages 6-8 (January 2010)
Volume 88, Issue 2, Pages (August 2015)
Volume 72, Issue 1, Pages (July 2007)
Volume 54, Issue 1, Pages (July 1998)
Assessing acid–base disorders
Comorbidity and confounding in end-stage renal disease
Proinflammatory effects of iron sucrose in chronic kidney disease
Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion  Lynda A. Frassetto, Eileen Nash,
Volume 70, Issue 11, Pages (December 2006)
Joseph W. Eschbach, John W. Adamson  Kidney International 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 54, Issue 5, Pages (November 1998)
Volume 76, Issue 1, Pages (July 2009)
Volume 87, Issue 2, Pages (February 2015)
Volume 77, Pages S8-S11 (March 2010)
Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments  R. Mishler, J.J. Sands, N.J. Ofsthun,
The calcium–phosphorus in guidelines for CKD-MBD
Fructose intake as a risk factor for kidney stone disease
Joel D. Kopple, Kamyar Kalantar-Zadeh, Rajnish Mehrotra 
Structure, not just function
Volume 76, Issue 6, Pages (September 2009)
Volume 87, Issue 1, Pages (January 2015)
Cardiac arrest and sudden death in dialysis units
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Volume 93, Issue 1, Pages (January 2018)
Reduced renal function in patients with simple renal cysts
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Keng-Thye Woo, Yeow-Kok Lau, Kok-Seng Wong, Gilbert Shih-Chen Chiang 
Volume 79, Issue 2, Pages (January 2011)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 62, Pages S47-S52 (December 2002)
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Volume 55, Issue 5, Pages (May 1999)
Volume 57, Issue 2, Pages (October 2000)
Volume 75, Issue 6, Pages (March 2009)
Association of urinary pH with body weight in nephrolithiasis
Volume 64, Issue 6, Pages (December 2003)
H.J. Heller, J.E. Zerwekh, F.A. Gottschalk, C.Y.C. Pak 
Volume 63, Issue 2, Pages (February 2003)
Jacob Lemann, Nancy D. Adams, Donald R. Wilz, Luis G. Brenes 
Role of sodium in hemodialysis
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate  S. Aime, C. Canavese, P. Stratta  Kidney International 
Volume 70, Issue 5, Pages (September 2006)
Volume 79, Issue 4, Pages (February 2011)
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
Metabolic Acidosis in CKD: Core Curriculum 2019
Volume 67, Issue 1, Pages (January 2005)
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Ronen Levi, Justin Silver  Kidney International 
Biochemical profile of idiopathic uric acid nephrolithiasis
Yoshitsugu Kaku, Kaoru Nohara, Sunao Honda  Kidney International 
Presentation transcript:

Volume 63, Issue 1, Pages 240-247 (January 2003) Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis  Clarita V. Odvina, Glenn M. Preminger, Jill S. Lindberg, Orson W. Moe, Charles Y.C. Pak  Kidney International  Volume 63, Issue 1, Pages 240-247 (January 2003) DOI: 10.1046/j.1523-1755.2003.00719.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Individual serum potassium values during combined treatment with thiazide and potassium citrate. Majority of the values were within normal limits. Thirteen determinations (from six patients) were less than 3.5 mEq/L. The patient who had persistent hypokalemia from months 8 to 32 was taking a large dose of hydrochlorothiazide (100 mg/day) and had both absorptive hypercalciuria and incomplete renal tubular acidosis. Dashed horizontal lines indicate the normal range. Individual points are depicted. Some points appear darker than others because of close similarity in values among several samples. Kidney International 2003 63, 240-247DOI: (10.1046/j.1523-1755.2003.00719.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Individual serum chloride values during combined treatment with thiazide and potassium citrate. During combined therapy, the majority of the patients remained normochloremic. Only five patients developed transient decrease in serum chloride concentration, and six had serum chloride concentrations>108 mEq/L. Dashed horizontal lines indicate the normal range. Kidney International 2003 63, 240-247DOI: (10.1046/j.1523-1755.2003.00719.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Individual serum bicarbonate [total carbon dioxide (CO2)] concentrations during combined treatment with thiazide and potassium citrate. Most of the values were within normal limits during combined therapy. Only three out of 401 determinations were <20 mEq/L and six determinations from four patients were>32 mEq/L. The dashed horizontal lines indicate the normal range. Kidney International 2003 63, 240-247DOI: (10.1046/j.1523-1755.2003.00719.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Individual urinary chloride concentrations before and during treatment. Urinary chloride concentration was rarely (three out of 154 determinations) below 15 mEq/L during combined therapy. Kidney International 2003 63, 240-247DOI: (10.1046/j.1523-1755.2003.00719.x) Copyright © 2003 International Society of Nephrology Terms and Conditions